Jump to content

Alfetamine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Ffffrr (talk | contribs) at 12:21, 1 September 2022 (Importing Wikidata short description: "Chemical compound"). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Alfetamine
Clinical data
Other namesAlfetadrinum
ATC code
  • none
Identifiers
  • 1-phenylpent-4-en-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H15N
Molar mass161.248 g·mol−1
3D model (JSmol)
  • NC(Cc1ccccc1)C\C=C
  • InChI=1S/C11H15N/c1-2-6-11(12)9-10-7-4-3-5-8-10/h2-5,7-8,11H,1,6,9,12H2 checkY
  • Key:WQKXQJYCZMWOSD-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Alfetamine, or alpha-allyl-phenethylamine, is a chemical compound of the phenethylamine family. It was briefly investigated as a possible antidepressant in the early 1970s. Its activity profile was said to be very similar to imipramine and amitriptyline, two tricyclic antidepressants.[1] It has now been largely superseded by the newer compounds in this class, and only rarely found in scientific literature. The "alpha" in its name refers to its prodrug form, alfetamine. In addition to being an antidepressant, alfetamine is also a neuroprotective agent that acts as a weak dopamine antagonist and a high affinity κ-opioid receptor agonist.

Alfetamine was synthesized by Kenji Tsukada and colleagues at Shinshu University and Dow Chemical Company in the 1960s and early 1970s.

References

  1. ^ Hitchens JT, Orzechowski R, Goldstein S, Shemano I (March 1972). "Pharmacologic evaluation of aletamine (alpha-allylphenethylamine hydrochloride) as an antidepressant". Toxicology and Applied Pharmacology. 21 (3): 302–14. doi:10.1016/0041-008X(72)90150-0. PMID 5063697.